DK1189602T3 - Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem - Google Patents

Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem

Info

Publication number
DK1189602T3
DK1189602T3 DK00940460T DK00940460T DK1189602T3 DK 1189602 T3 DK1189602 T3 DK 1189602T3 DK 00940460 T DK00940460 T DK 00940460T DK 00940460 T DK00940460 T DK 00940460T DK 1189602 T3 DK1189602 T3 DK 1189602T3
Authority
DK
Denmark
Prior art keywords
preparation
microgranules
morphine
preparation containing
morphine microgranules
Prior art date
Application number
DK00940460T
Other languages
Danish (da)
English (en)
Inventor
Dominique Marechal
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9546553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1189602(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of DK1189602T3 publication Critical patent/DK1189602T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DK00940460T 1999-06-09 2000-06-08 Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem DK1189602T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9907259A FR2794646B1 (fr) 1999-06-09 1999-06-09 Microgranules de sulfate de morphine, procede de preparation et composition les contenant
PCT/FR2000/001573 WO2000074659A1 (fr) 1999-06-09 2000-06-08 Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Publications (1)

Publication Number Publication Date
DK1189602T3 true DK1189602T3 (da) 2007-07-02

Family

ID=9546553

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05111290.2T DK1627631T3 (da) 1999-06-09 2000-06-08 Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
DK00940460T DK1189602T3 (da) 1999-06-09 2000-06-08 Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK05111290.2T DK1627631T3 (da) 1999-06-09 2000-06-08 Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme

Country Status (24)

Country Link
US (2) US7063864B1 (de)
EP (3) EP1627631B1 (de)
JP (1) JP4296562B2 (de)
KR (1) KR100676123B1 (de)
CN (1) CN1267089C (de)
AR (2) AR024313A1 (de)
AT (2) ATE354356T1 (de)
AU (1) AU769160C (de)
BR (1) BRPI0011404B8 (de)
CA (1) CA2376339C (de)
CO (1) CO5160317A1 (de)
CY (1) CY1107612T1 (de)
DE (1) DE60033519T2 (de)
DK (2) DK1627631T3 (de)
ES (2) ES2379688T3 (de)
FR (1) FR2794646B1 (de)
HK (1) HK1045107B (de)
MX (1) MXPA01012751A (de)
NZ (1) NZ516077A (de)
PT (2) PT1189602E (de)
SI (1) SI1189602T1 (de)
TW (1) TWI224510B (de)
WO (1) WO2000074659A1 (de)
ZA (1) ZA200110087B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1610767B1 (de) 2003-03-26 2011-01-19 Egalet A/S Morphin-system mit kontrollierter freisetzung
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (de) 2009-06-24 2012-05-02 Egalet Ltd. Retard-formulierungen
US20190038769A1 (en) * 2010-12-01 2019-02-07 Gowey Research Group, Pllc Micro-rna profiling, compositions, and methods of treating diseases
JP2012250926A (ja) * 2011-06-01 2012-12-20 Nitto Denko Corp 粒子製剤
CA2877183A1 (en) 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514665D0 (en) 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
GB9119958D0 (en) 1991-09-18 1991-10-30 Unilever Plc Detergent compositions
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
SE9301057L (sv) 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
EP2036558A3 (de) * 1993-10-07 2010-04-28 Euro-Celtique S.A. Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5460826A (en) 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Also Published As

Publication number Publication date
US7063864B1 (en) 2006-06-20
HK1045107A1 (en) 2002-11-15
ATE354356T1 (de) 2007-03-15
BR0011404B1 (pt) 2013-03-05
FR2794646B1 (fr) 2001-09-21
AU769160C (en) 2006-02-23
JP4296562B2 (ja) 2009-07-15
CN1390121A (zh) 2003-01-08
CA2376339A1 (fr) 2000-12-14
ES2280226T3 (es) 2007-09-16
KR20020031338A (ko) 2002-05-01
ATE544448T1 (de) 2012-02-15
AR068015A2 (es) 2009-10-28
BRPI0011404B8 (pt) 2021-05-25
EP1627631A2 (de) 2006-02-22
US20070003620A1 (en) 2007-01-04
AR024313A1 (es) 2002-09-25
EP1627631A3 (de) 2006-03-15
EP1627631B1 (de) 2012-02-08
KR100676123B1 (ko) 2007-01-31
CO5160317A1 (es) 2002-05-30
HK1045107B (zh) 2007-05-11
FR2794646A1 (fr) 2000-12-15
DE60033519T2 (de) 2007-10-31
BR0011404A (pt) 2002-03-05
ZA200110087B (en) 2003-03-03
DK1627631T3 (da) 2012-04-30
CY1107612T1 (el) 2013-03-13
MXPA01012751A (es) 2002-07-02
EP1818051A1 (de) 2007-08-15
WO2000074659A1 (fr) 2000-12-14
PT1627631E (pt) 2012-05-21
EP1189602A1 (de) 2002-03-27
NZ516077A (en) 2004-06-25
AU769160B2 (en) 2004-01-15
PT1189602E (pt) 2007-05-31
CN1267089C (zh) 2006-08-02
CA2376339C (fr) 2011-05-17
SI1189602T1 (sl) 2007-06-30
EP1189602B1 (de) 2007-02-21
DE60033519D1 (de) 2007-04-05
AU5539400A (en) 2000-12-28
JP2003520770A (ja) 2003-07-08
TWI224510B (en) 2004-12-01
ES2379688T3 (es) 2012-04-30

Similar Documents

Publication Publication Date Title
PL318278A1 (en) Novel heteroaryl oxazolydinones, method of obtaining and drugs containing them
PL317929A1 (en) Pyrido-condenset thenyl- and furanyl oxazolydinones, method of obtaining and drugs containing them
DK1023382T3 (da) Sammensat proppant, sammensatte filtreringsmidler og fremgangsmåder til fremstilling og anvendelse deraf
IS5560A (is) Efnablanda með tafða losun, aðferð til að framleiða hana og notkun hennar
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1189602T3 (da) Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
NO20010309D0 (no) Ikke-peptidiske midler for inhibering av gonatropinfrigjörende hormoner, samt fremgangsmåter og mellomprodukter til fremstilling derav
PL318277A1 (en) Novel substituted axazolydinones, method of obtaining and drugs containing them
PL330841A1 (en) Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
IS6197A (is) Aðferð og búnaður til að koma lyfjablöndum á úðaform
DK1206495T3 (da) Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf
NO20032332L (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
HUP0100347A3 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
GB2368863B (en) Well packer and method
PL341590A1 (en) Novel aromatic amides, method of obtaining them and their application as drugs
NO20023161D0 (no) Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem
DK0912613T3 (da) Syntetiske polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
PL341619A1 (en) Derivatives of cyclobutane, method of obtaining them and their therapeutic application
DK1178799T3 (da) Gastrobeskyttede mikrogranula, fremgangsmåde til opnåelse af samme og farmaceutiske præparater
NO995579D0 (no) Fremgangsmåte og anordning til fremstilling av tannbörste, tannbörste, samt anvendelse av tannbörsten
NO20023000D0 (no) System og fremgangsmåte for telemetri i et borehull